Jan Frystyk

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Frederiksen L; Nielsen T L; Wraae K; Hagen C; Frystyk J; Flyvbjerg A; Brixen K; Andersen M
Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men.
Laurberg Trine Bay; Frystyk Jan; Ellingsen Torkell; Hansen Ib T; Jørgensen Anette; Tarp Ulrik; Hetland Merete Lund; Hørslev-Petersen Kim; Hornung Nete; Poulsen Jørgen Hjelm; Flyvbjerg Allan; Stengaard-Pedersen Kristian
Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls.
Krag Morten B; Rasmussen Lars M; Hansen Troels K; Frystyk Jan; Flyvbjerg Allan; Møller Niels; Jørgensen Jens O L
Peroxisome proliferator-activated receptor gamma (PPAR) agonism reduces the insulin-stimulated increase in circulating interleukin-6 in GH replaced GH-deficient adults.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jan Frystyk (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Frederiksen L; Nielsen T L; Wraae K; Hagen C; Frystyk J; Flyvbjerg A; Brixen K; Andersen M
Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men.
The Journal of clinical endocrinology and metabolism 2009;94(10):4010-5.
2009: Laurberg Trine Bay; Frystyk Jan; Ellingsen Torkell; Hansen Ib T; Jørgensen Anette; Tarp Ulrik; Hetland Merete Lund; Hørslev-Petersen Kim; Hornung Nete; Poulsen Jørgen Hjelm; Flyvbjerg Allan; Stengaard-Pedersen Kristian
Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls.
The Journal of rheumatology 2009;36(9):1885-91.
2009: Krag Morten B; Rasmussen Lars M; Hansen Troels K; Frystyk Jan; Flyvbjerg Allan; Møller Niels; Jørgensen Jens O L
Peroxisome proliferator-activated receptor gamma (PPAR) agonism reduces the insulin-stimulated increase in circulating interleukin-6 in GH replaced GH-deficient adults.
Clinical endocrinology 2009;71(3):363-8.
2009: Weiss Ram; Otvos James D; Flyvbjerg Allan; Miserez Andre R; Frystyk Jan; Sinnreich Ronit; Kark Jeremy D
Adiponectin and lipoprotein particle size.
Diabetes care 2009;32(7):1317-9.
2009: Holland-Fischer Peter; Vilstrup Hendrik; Frystyk Jan; Nielsen Dennis Tønner; Flyvbjerg Allan; Grønbaek Henning
The IGF system after insertion of a transjugular intrahepatic porto-systemic shunt in patients with liver cirrhosis.
European journal of endocrinology / European Federation of Endocrine Societies 2009;160(6):957-63.
2009: Markovitch Daniella; Tyrrell Rex M; Tauler Pedro; Frystyk Jan; Stokes Keith; Thompson Dylan
Lycopene supplementation (passata sauce) reduces apoptosis but does not affect oxidant-responsive heme oxygenase-1 in human lymphocytes.
Nutrition (Burbank, Los Angeles County, Calif.) 2009;25(6):668-75.
2009: Kuan Ying; Surman Joanne; Frystyk Jan; El Nahas A Meguid; Flyvbjerg Allan; Haylor John L
Lack of effect of IGF-I on the glomerular filtration rate in non-diabetic patients with advanced chronic kidney disease.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2009;19(3):219-25.
2009: Pokrajac Ana; Frystyk Jan; Flyvbjerg Allan; Trainer Peter J
Pituitary-independent effect of octreotide on IGF1 generation.
European journal of endocrinology / European Federation of Endocrine Societies 2009;160(4):543-8.
2009: Hansen Mette; Kongsgaard Mads; Holm Lars; Skovgaard Dorthe; Magnusson S Peter; Qvortrup Klaus; Larsen Jytte O; Aagaard Per; Dahl Morten; Serup Annette; Frystyk Jan; Flyvbjerg Allan; Langberg Henning; Kjaer Michael
Effect of estrogen on tendon collagen synthesis, tendon structural characteristics, and biomechanical properties in postmenopausal women.
Journal of applied physiology (Bethesda, Md. : 1985) 2009;106(4):1385-93.
2009: Støving René Klinkby; Andries Alin; Brixen Kim; Flyvbjerg Allan; Hørder Kirsten; Frystyk Jan
Leptin, ghrelin, and endocannabinoids: potential therapeutic targets in anorexia nervosa.
Journal of psychiatric research 2009;43(7):671-9.
2009: Hansen M; Miller B F; Holm L; Doessing S; Petersen S G; Skovgaard D; Frystyk J; Flyvbjerg A; Koskinen S; Pingel J; Kjaer M; Langberg H
Effect of administration of oral contraceptives in vivo on collagen synthesis in tendon and muscle connective tissue in young women.
Journal of applied physiology (Bethesda, Md. : 1985) 2009;106(4):1435-43.
2009: Ingelsson Erik; Arnlöv Johan; Zethelius Björn; Vasan Ramachandran S; Flyvbjerg Allan; Frystyk Jan; Berne Christian; Hänni Arvo; Lind Lars; Sundström Johan
Associations of serum adiponectin with skeletal muscle morphology and insulin sensitivity.
The Journal of clinical endocrinology and metabolism 2009;94(3):953-7.
2009: Moller Louise; Dalman Lisa; Norrelund Helene; Billestrup Nils; Frystyk Jan; Moller Niels; Jorgensen Jens Otto Lunde
Impact of fasting on growth hormone signaling and action in muscle and fat.
The Journal of clinical endocrinology and metabolism 2009;94(3):965-72.
2009: Yakar Shoshana; Rosen Clifford J; Bouxsein Mary L; Sun Hui; Mejia Wilson; Kawashima Yuki; Wu Yingjie; Emerton Kelly; Williams Valerie; Jepsen Karl; Schaffler Mitchell B; Majeska Robert J; Gavrilova Oksana; Gutierrez Mariana; Hwang David; Pennisi Patricia; Frystyk Jan; Boisclair Yves; Pintar John; Jasper Héctor; Domene Horacio; Cohen Pinchas; Clemmons David; LeRoith Derek
Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2009;23(3):709-19.
2009: Glintborg Dorte; Hermann Anne Pernille; Hagen Claus; Jensen Lars Thorbjørn; Frystyk Jan; Bennett Paul; Flyvbjerg Allan; Andersen Marianne
A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome.
Fertility and sterility 2009;91(3):842-50.
2009: Langouche Lies; Vander Perre Sarah; Frystyk Jan; Flyvbjerg Allan; Hansen Troels Krarup; Van den Berghe Greet
Adiponectin, retinol-binding protein 4, and leptin in protracted critical illness of pulmonary origin.
Critical care (London, England) 2009;13(4):R112.
2008: Espelund Ulrick; Cold Søren; Frystyk Jan; Ørskov Hans; Flyvbjerg Allan
Elevated free IGF2 levels in localized, early-stage breast cancer in women.
European journal of endocrinology / European Federation of Endocrine Societies 2008;159(5):595-601.
2008: Michaëlsson Karl; Lind Lars; Frystyk Jan; Flyvbjerg Allan; Gedeborg Rolf; Berne Christian; Zethelius Björn; Mallmin Hans; Söderberg Stefan; Melhus Håkan
Serum adiponectin in elderly men does not correlate with fracture risk.
The Journal of clinical endocrinology and metabolism 2008;93(10):4041-7.
2008: Riis Anne Lene Dalkjaer; Jørgensen Jens Otto Lunde; Ivarsen Per; Frystyk Jan; Weeke Jørgen; Møller Niels
Increased protein turnover and proteolysis is an early and primary feature of short-term experimental hyperthyroidism in healthy women.
The Journal of clinical endocrinology and metabolism 2008;93(10):3999-4005.
2008: Amin R; Frystyk J; Ong K; Dalton R N; Flyvbjerg A; Dunger D B
The development of microalbuminuria is associated with raised longitudinal adiponectin levels in female but not male adolescent patients with type 1 diabetes.
Diabetologia 2008;51(9):1707-13.
2008: Jorsal Anders; Tarnow Lise; Frystyk Jan; Lajer Maria; Flyvbjerg Allan; Parving Hans-Henrik; Vionnet Nathalie; Rossing Peter
Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy.
Kidney international 2008;74(5):649-54.
2008: Leth Henrik; Andersen Kristian K; Frystyk Jan; Tarnow Lise; Rossing Peter; Parving Hans-Henrik; Flyvbjerg Allan
Elevated levels of high-molecular-weight adiponectin in type 1 diabetes.
The Journal of clinical endocrinology and metabolism 2008;93(8):3186-91.
2008: Frystyk Jan; Andreasen Caroline Marie; Fisker Sanne
Determination of free growth hormone.
The Journal of clinical endocrinology and metabolism 2008;93(8):3008-14.
2008: Brugts M P; van den Beld A W; Hofland L J; van der Wansem K; van Koetsveld P M; Frystyk J; Lamberts S W J; Janssen J A M J L
Low circulating insulin-like growth factor I bioactivity in elderly men is associated with increased mortality.
The Journal of clinical endocrinology and metabolism 2008;93(7):2515-22.
2008: Brugts Michael P; Ranke Michael B; Hofland Leo J; van der Wansem Katy; Weber Karin; Frystyk Jan; Lamberts Steven W J; Janssen Joseph A M J L
Normal values of circulating insulin-like growth factor-I bioactivity in the healthy population: comparison with five widely used IGF-I immunoassays.
The Journal of clinical endocrinology and metabolism 2008;93(7):2539-45.
2008: Kozakova Michaela; Muscelli Elza; Flyvbjerg Allan; Frystyk Jan; Morizzo Carmela; Palombo Carlo; Ferrannini Ele
Adiponectin and left ventricular structure and function in healthy adults.
The Journal of clinical endocrinology and metabolism 2008;93(7):2811-8.
2008: Hansen Mette; Koskinen Satu O; Petersen Susanne G; Doessing Simon; Frystyk Jan; Flyvbjerg Allan; Westh Eva; Magnusson S Peter; Kjaer Michael; Langberg Henning
Ethinyl oestradiol administration in women suppresses synthesis of collagen in tendon in response to exercise.
The Journal of physiology 2008;586(Pt 12):3005-16.
2008: Saraheimo Markku; Forsblom Carol; Thorn Lena; Wadén Johan; Rosengård-Bärlund Milla; Heikkilä Outi; Hietala Kustaa; Gordin Daniel; Frystyk Jan; Flyvbjerg Allan; Groop Per-Henrik;
Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
Diabetes care 2008;31(6):1165-9.
2008: Belobrajdic Damien P; Priebe Ilka K; Forbes Briony; Flyvbjerg Allan; Chen Jian-Wen; Cosgrove Leah J; Frystyk Jan; Saunders Ian W
Assessing the potential usefulness of IGF-related peptides and adiponectin for predicting disease risk.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2008;18(3):198-204.
2008: Frystyk Jan; Ritzel Robert A; Maubach J; Büsing Martin; Lück Rainer; Klempnauer Jürgen; Schmiegel Wolff; Nauck Michael A
Comparison of pancreas-transplanted type 1 diabetic patients with portal-venous versus systemic-venous graft drainage: impact on glucose regulatory hormones and the growth hormone/insulin-like growth factor-I axis.
The Journal of clinical endocrinology and metabolism 2008;93(5):1758-66.
2008: Joseph Gowsini; Tarnow Lise; Astrup Anne Sofie; Hansen Troels Krarup; Parving Hans-Henrik; Flyvbjerg Allan; Frystyk Jan
Plasma alpha-defensin is associated with cardiovascular morbidity and mortality in type 1 diabetic patients.
The Journal of clinical endocrinology and metabolism 2008;93(4):1470-5.
2008: Saraheimo M; Forsblom C; Pettersson-Fernholm K; Flyvbjerg A; Groop P-H; Frystyk J;
Increased levels of alpha-defensin (-1, -2 and -3) in type 1 diabetic patients with nephropathy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(3):914-8.
2008: Jensen Rikke Beck; Vielwerth Signe; Frystyk Jan; Veldhuis Johannes; Larsen Torben; Mølgaard Christian; Greisen Gorm; Juul Anders
Fetal growth velocity, size in early life and adolescence, and prediction of bone mass: association to the GH-IGF axis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2008;23(3):439-46.
2008: Patel Sheila; Flyvbjerg Allan; Kozàkovà Michaela; Frystyk Jan; Ibrahim Ibrahim M; Petrie John R; Avery Peter J; Ferrannini Ele; Walker Mark;
Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects.
European heart journal 2008;29(3):386-93.
2008: Glintborg Dorte; Frystyk Jan; Højlund Kurt; Andersen Kristian Kjaer; Henriksen Jan Erik; Hermann Anne Pernille; Hagen Claus; Flyvbjerg Allan; Andersen Marianne
Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome.
Clinical endocrinology 2008;68(2):165-74.
2007: Beardsall Kathryn; Ogilvy-Stuart Amanda L; Frystyk Jan; Chen Jian-Wen; Thompson Mike; Ahluwalia Jag; Ong Ken K; Dunger David B
Early elective insulin therapy can reduce hyperglycemia and increase insulin-like growth factor-I levels in very low birth weight infants.
The Journal of pediatrics 2007;151(6):611-7, 617.e1.
2007: Domené Horacio M; Scaglia Paula A; Lteif Aida; Mahmud Farid H; Kirmani Salman; Frystyk Jan; Bedecarrás Patricia; Gutiérrez Mariana; Jasper Héctor G
Phenotypic effects of null and haploinsufficiency of acid-labile subunit in a family with two novel IGFALS gene mutations.
The Journal of clinical endocrinology and metabolism 2007;92(11):4444-50.
2007: Ørskov H; Frystyk J; Nielsen C; Hansen A T; Weeke J; Jørgensen J O L
Concomitant, specific determination of growth hormone and pegvisomant in human serum.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2007;17(5):431-4.
2007: Støving René Klinkby; Chen Jian-Wen; Glintborg Dorte; Brixen Kim; Flyvbjerg Allan; Hørder Kirsten; Frystyk Jan
Bioactive insulin-like growth factor (IGF) I and IGF-binding protein-1 in anorexia nervosa.
The Journal of clinical endocrinology and metabolism 2007;92(6):2323-9.
2007: Renehan Andrew G; Frystyk Jan; Howell Anthony; O'dwyer Sarah T; Shalet Stephen M; Flyvbjerg Allan
The effects of sex steroid replacement therapy on an expanded panel of IGF-related peptides.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2007;17(3):210-9.
2007: Nauck Michael A; Reinecke Manfred; Perren Aurel; Frystyk Jan; Berishvili Giorgi; Zwimpfer Cornelia; Figge Anja M; Flyvbjerg Allan; Lankisch Paul G; Blum Werner F; Klöppel Günter; Schmiegel Wolff; Zapf Jürgen
Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I in a patient with metastasizing large-cell carcinoma of the lung.
The Journal of clinical endocrinology and metabolism 2007;92(5):1600-5.
2007: Andersen Kristian Kjaer; Frystyk Jan; Wolthers Ole D; Heuck Carsten; Flyvbjerg Allan
Gender differences of oligomers and total adiponectin during puberty: a cross-sectional study of 859 Danish school children.
The Journal of clinical endocrinology and metabolism 2007;92(5):1857-62.
2007: Eivindson Martin; Grønbaek Henning; Skogstrand Kristin; Thorsen Poul; Frystyk Jan; Flyvbjerg Allan; Dahlerup Jens F
The insulin-like growth factor (IGF) system and its relation to infliximab treatment in adult patients with Crohn's disease.
Scandinavian journal of gastroenterology 2007;42(4):464-70.
2007: Jørgensen Jens Otto Lunde; Feldt-Rasmussen Ulla; Frystyk Jan; Chen Jian-Wen; Kristensen Lars Østergård; Hagen Claus; Ørskov Hans
[Medical co-treatment af acromegaly with a somatostatin analogue and a growth hormone receptor antagonist]
Ugeskrift for laeger 2007;169(10):911-3.
2007: Eivindson Martin; Grønbaek Henning; Flyvbjerg Allan; Frystyk Jan; Zimmermann-Nielsen Erik; Dahlerup Jens Frederik
The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn's disease: relations to disease activity and corticosteroid treatment.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2007;17(1):33-40.
2007: Frystyk Jan; Berne Christian; Berglund Lars; Jensevik Karin; Flyvbjerg Allan; Zethelius Björn
Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men.
The Journal of clinical endocrinology and metabolism 2007;92(2):571-6.
2007: Frystyk Jan
Utility of free IGF-I measurements.
Pituitary 2007;10(2):181-7.
2007: Domené Horacio M; Martínez Alicia S; Frystyk Jan; Bengolea Sonia V; Ropelato María G; Scaglia Paula A; Chen Jian-Wen; Heuck Carsten; Wolthers Ole D; Heinrich Juan J; Jasper Héctor G
Normal growth spurt and final height despite low levels of all forms of circulating insulin-like growth factor-I in a patient with acid-labile subunit deficiency.
Hormone research 2007;67(5):243-9.
2006: Lindström Torbjörn; Frystyk Jan; Hedman Christina A; Flyvbjerg Allan; Arnqvist Hans J
Elevated circulating adiponectin in type 1 diabetes is associated with long diabetes duration.
Clinical endocrinology 2006;65(6):776-82.
2006: Nilsson Peter M; Engström Gunnar; Hedblad Bo; Frystyk Jan; Persson Margaretha M; Berglund Göran; Flyvbjerg Allan
Plasma adiponectin levels in relation to carotid intima media thickness and markers of insulin resistance.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(12):2758-62.
2006: Gravholt Claus Højbjerg; Chen Jian-Wen; Oxvig Claus; Overgaard Michael T; Christiansen Jens Sandahl; Frystyk Jan; Flyvbjerg Allan
The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2006;16(5-6):332-9.
2006: Gravholt Claus Højbjerg; Hjerrild Britta Eilersen; Mosekilde Leif; Hansen Troels Krarup; Rasmussen Lars Melholt; Frystyk Jan; Flyvbjerg Allan; Christiansen Jens Sandahl
Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules.
European journal of endocrinology / European Federation of Endocrine Societies 2006;155(4):583-92.
2006: Renehan Andrew G; Frystyk Jan; Flyvbjerg Allan
Obesity and cancer risk: the role of the insulin-IGF axis.
Trends in endocrinology and metabolism: TEM 2006;17(8):328-36.
2006: Ning Yun; Schuller Alwin G P; Bradshaw Sheri; Rotwein Peter; Ludwig Thomas; Frystyk Jan; Pintar John E
Diminished growth and enhanced glucose metabolism in triple knockout mice containing mutations of insulin-like growth factor binding protein-3, -4, and -5.
Molecular endocrinology (Baltimore, Md.) 2006;20(9):2173-86.
2006: Ryber Louise; Obrink Kristina; Houe Nanna; Frystyk Jan; Jørgensen Jens Otto Lunde
Serum ghrelin levels are suppressed in hypopituitary patients following insulin-induced hypoglycaemia irrespective of GH status.
Clinical endocrinology 2006;65(2):210-4.
2006: Glintborg Dorte; Andersen Marianne; Hagen Claus; Frystyk Jan; Hulstrøm Veronica; Flyvbjerg Allan; Hermann Anne Pernille
Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls.
European journal of endocrinology / European Federation of Endocrine Societies 2006;155(2):337-45.
2006: Møller Anne Vestergård; Jørgensen Søren Peter; Chen Jian-Wen; Larnkjaer Anni; Ledet Thomas; Flyvbjerg Allan; Frystyk Jan
Glycosaminoglycans increase levels of free and bioactive IGF-I in vitro.
European journal of endocrinology / European Federation of Endocrine Societies 2006;155(2):297-305.
2006: Chen Jian-Wen; Nielsen Michael F; Caumo Andrea; Vilstrup Hendrik; Christiansen Jens Sandahl; Frystyk Jan
Changes in bioactive IGF-I and IGF-binding protein-1 during an oral glucose tolerance test in patients with liver cirrhosis.
European journal of endocrinology / European Federation of Endocrine Societies 2006;155(2):285-92.
2006: Bojesen Anders; Kristensen Kurt; Birkebaek Niels H; Fedder Jens; Mosekilde Leif; Bennett Paul; Laurberg Peter; Frystyk Jan; Flyvbjerg Allan; Christiansen Jens S; Gravholt Claus H
The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism.
Diabetes care 2006;29(7):1591-8.
2006: Højlund K; Frystyk J; Levin K; Flyvbjerg A; Wojtaszewski J F P; Beck-Nielsen H
Reduced plasma adiponectin concentrations may contribute to impaired insulin activation of glycogen synthase in skeletal muscle of patients with type 2 diabetes.
Diabetologia 2006;49(6):1283-91.
2006: Hjelmesaeth Jøran; Flyvbjerg Allan; Jenssen Trond; Frystyk Jan; Ueland Thor; Hagen Monica; Hartmann Anders
Hypoadiponectinemia is associated with insulin resistance and glucose intolerance after renal transplantation: impact of immunosuppressive and antihypertensive drug therapy.
Clinical journal of the American Society of Nephrology : CJASN 2006;1(3):575-82.
2006: Fuglsang Jens; Sandager Puk; Møller Niels; Fisker Sanne; Frystyk Jan; Ovesen Per
Peripartum maternal and foetal ghrelin, growth hormones, IGFs and insulin interrelations.
Clinical endocrinology 2006;64(5):502-9.
2006: Ong Ken K; Frystyk Jan; Flyvbjerg Allan; Petry Clive J; Ness Andy; Dunger David B
Sex-discordant associations with adiponectin levels and lipid profiles in children.
Diabetes 2006;55(5):1337-41.
2006: Ingelsson Erik; Risérus Ulf; Berne Christian; Frystyk Jan; Flyvbjerg Allan; Axelsson Tomas; Lundmark Per; Zethelius Björn
Adiponectin and risk of congestive heart failure.
JAMA : the journal of the American Medical Association 2006;295(15):1772-4.
2006: Camacho-Hübner Cecilia; Rose Stephen; Preece Michael A; Sleevi Mark; Storr Helen L; Miraki-Moud Farideh; Minuto Francesco; Frystyk Jan; Rogol Alan; Allan Geoffrey; Sommer Andreas; Savage Martin O
Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome.
The Journal of clinical endocrinology and metabolism 2006;91(4):1246-53.
2006: Fuglsang Jens; Skjaerbaek Christian; Frystyk Jan; Flyvbjerg Allan; Ovesen Per
A longitudinal study of serum adiponectin during normal pregnancy.
BJOG : an international journal of obstetrics and gynaecology 2006;113(1):110-3.
2005: Espelund Ulrick; Bruun Jens Meldgaard; Richelsen Bjørn; Flyvbjerg Allan; Frystyk Jan
Pro- and mature IGF-II during diet-induced weight loss in obese subjects.
European journal of endocrinology / European Federation of Endocrine Societies 2005;153(6):861-9.
2005: Frystyk Jan
Aging somatotropic axis: mechanisms and implications of insulin-like growth factor-related binding protein adaptation.
Endocrinology and metabolism clinics of North America 2005;34(4):865-76, viii.
2005: Eivindson Martin; Grønbaek Henning; Nielsen Jens Nederby; Frystyk Jan; Flyvbjerg Allan; Jørgensen Lone; Vind Ida; Munkholm Pia; Jensen Søren; Brandslund Ivan; Hey Henrik
Insulin-like growth factors (IGFs) and IGF binding proteins in active Crohn's disease treated with omega-3 or omega-6 fatty acids and corticosteroids.
Scandinavian journal of gastroenterology 2005;40(10):1214-21.
2005: Yuen Kevin C J; Frystyk Jan; White Deborah K; Twickler Th B; Koppeschaar Hans P F; Harris Philip E; Fryklund Linda; Murgatroyd Peter R; Dunger David B
Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
Clinical endocrinology 2005;63(4):428-36.
2005: Glintborg Dorte; Støving René Klinkby; Hagen Claus; Hermann Anne Pernille; Frystyk Jan; Veldhuis Johannes D; Flyvbjerg Allan; Andersen Marianne
Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndrome.
The Journal of clinical endocrinology and metabolism 2005;90(10):5605-12.
2005: Jørgensen Jens Otto Lunde; Feldt-Rasmussen Ulla; Frystyk Jan; Chen Jian-Wen; Kristensen Lars Østergård; Hagen Claus; Ørskov Hans
Cotreatment of acromegaly with a somatostatin analog and a growth hormone receptor antagonist.
The Journal of clinical endocrinology and metabolism 2005;90(10):5627-31.
2005: Conchillo Mariam; de Knegt Robert J; Payeras Marina; Quiroga Jorge; Sangro Bruno; Herrero Jose-Ignacio; Castilla-Cortazar Inma; Frystyk Jan; Flyvbjerg Allan; Yoshizawa Carl; Jansen Peter L M; Scharschmidt Bruce; Prieto Jesús
Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial.
Journal of hepatology 2005;43(4):630-6.
2005: Stokes Keith; Nevill Mary; Frystyk Jan; Lakomy Henryk; Hall George
Human growth hormone responses to repeated bouts of sprint exercise with different recovery periods between bouts.
Journal of applied physiology (Bethesda, Md. : 1985) 2005;99(4):1254-61.
2005: Kistorp Caroline; Faber Jens; Galatius Søren; Gustafsson Finn; Frystyk Jan; Flyvbjerg Allan; Hildebrandt Per
Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.
Circulation 2005;112(12):1756-62.
2005: Frystyk J; Tarnow L; Hansen T Krarup; Parving H-H; Flyvbjerg A
Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications.
Diabetologia 2005;48(9):1911-8.
2005: Hedman Christina A; Frystyk Jan; Fridell Karin; Jönsson Anna; Flyvbjerg Allan; Lindström Torbjörn; Arnqvist Hans J
The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2005;15(4):304-10.
2005: Kanaley J A; Frystyk J; Møller N; Dall R; Chen J-W; Nielsen Sven C; Christiansen J S; Jørgensen J O L; Flyvbjerg A
The effect of submaximal exercise on immuno- and bioassayable IGF-I activity in patients with GH-deficiency and healthy subjects.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2005;15(4):283-90.
2005: Grønbaek H; Flyvbjerg A; Winding P; Frystyk J; Hey H
Effects of pure ethanol and alcopops on glucose, insulin, and the insulin-like growth factor system in healthy subjects.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2005;15(4):243-50.
2005: Saraheimo Markku; Forsblom Carol; Fagerudd Johan; Teppo Anna-Maija; Pettersson-Fernholm Kim; Frystyk Jan; Flyvbjerg Allan; Groop Per-Henrik;
Serum adiponectin is increased in type 1 diabetic patients with nephropathy.
Diabetes care 2005;28(6):1410-4.
2005: Fuglsang Jens; Skjaerbaek Christian; Espelund Ulrick; Frystyk Jan; Fisker Sanne; Flyvbjerg Allan; Ovesen Per
Ghrelin and its relationship to growth hormones during normal pregnancy.
Clinical endocrinology 2005;62(5):554-9.
2005: Veldhuis Johannes D; Frystyk Jan; Iranmanesh Ali; Ørskov Hans
Testosterone and estradiol regulate free insulin-like growth factor I (IGF-I), IGF binding protein 1 (IGFBP-1), and dimeric IGF-I/IGFBP-1 concentrations.
The Journal of clinical endocrinology and metabolism 2005;90(5):2941-7.
2005: Amin Rakesh; Williams Rachel M; Frystyk January; Umpleby Margot; Matthews David; Orskov Hans; Dalton R Neil; Dunger David B
Increasing urine albumin excretion is associated with growth hormone hypersecretion and reduced clearance of insulin in adolescents and young adults with type 1 diabetes: the Oxford Regional Prospective Study.
Clinical endocrinology 2005;62(2):137-44.
2005: Espelund Ulrick; Hansen Troels Krarup; Højlund Kurt; Beck-Nielsen Henning; Clausen Jes Thorn; Hansen Birgit Sehested; Orskov Hans; Jørgensen Jens Otto Lunde; Frystyk Jan
Fasting unmasks a strong inverse association between ghrelin and cortisol in serum: studies in obese and normal-weight subjects.
The Journal of clinical endocrinology and metabolism 2005;90(2):741-6.
2005: Chen Jian-Wen; Højlund Kurt; Beck-Nielsen Henning; Sandahl Christiansen Jens; Orskov Hans; Frystyk Jan
Free rather than total circulating insulin-like growth factor-I determines the feedback on growth hormone release in normal subjects.
The Journal of clinical endocrinology and metabolism 2005;90(1):366-71.
2004: Hedman Christina A; Frystyk Jan; Lindström Torbjörn; Chen Jian-Wen; Flyvbjerg Allan; Ørskov Hans; Arnqvist Hans J
Residual beta-cell function more than glycemic control determines abnormalities of the insulin-like growth factor system in type 1 diabetes.
The Journal of clinical endocrinology and metabolism 2004;89(12):6305-9.
2004: Hoybye Charlotte; Bruun Jens M; Richelsen Bjorn; Flyvbjerg Allan; Frystyk Jan
Serum adiponectin levels in adults with Prader-Willi syndrome are independent of anthropometrical parameters and do not change with GH treatment.
European journal of endocrinology / European Federation of Endocrine Societies 2004;151(4):457-61.
2004: Frystyk Jan
Free insulin-like growth factors -- measurements and relationships to growth hormone secretion and glucose homeostasis.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2004;14(5):337-75.
2004: Cingel-Ristic Vesna; Van Neck Johan W; Frystyk Jan; Drop Stenvert L S; Flyvbjerg Allan
Administration of human insulin-like growth factor-binding protein-1 increases circulating levels of growth hormone in mice.
Endocrinology 2004;145(9):4401-7.
2004: Yuen Kevin; Frystyk Jan; Umpleby Margot; Fryklund Linda; Dunger David
Changes in free rather than total insulin-like growth factor-I enhance insulin sensitivity and suppress endogenous peak growth hormone (GH) release following short-term low-dose GH administration in young healthy adults.
The Journal of clinical endocrinology and metabolism 2004;89(8):3956-64.
2004: Krassas Gerasimos; Pontikides Nikolaos; Dumas Argyrios; Frystyk Jan; Chen Jian-Wen; Flyvbjerg Allan
The effect of long-term somatostatin analogue treatment on free and total insulin-like growth factor (IGF) -I, -II and IGF binding protein -1, -2 and -3 serum levels in euthyroid patients with active thyroid eye disease.
Hormones (Athens, Greece) 2004;3(3):191-7.
2004: Yuen Kevin; Wareham Nicholas; Frystyk Jan; Hennings Susie; Mitchell Jo; Fryklund Linda; Dunger David
Short-term low-dose growth hormone administration in subjects with impaired glucose tolerance and the metabolic syndrome: effects on beta-cell function and post-load glucose tolerance.
European journal of endocrinology / European Federation of Endocrine Societies 2004;151(1):39-45.
2004: Veldhuis Johannes D; Anderson Stacey M; Kok Petra; Iranmanesh Ali; Frystyk Jan; Ørskov Hans; Keenan Daniel M
Estradiol supplementation modulates growth hormone (GH) secretory-burst waveform and recombinant human insulin-like growth factor-I-enforced suppression of endogenously driven GH release in postmenopausal women.
The Journal of clinical endocrinology and metabolism 2004;89(3):1312-8.
2004: Skjaerbaek Christian; Frystyk Jan; Orskov Hans; Flyvbjerg Allan
Free IGF-I, IGFBP-1, and the binary complex of IGFBP-1 and IGF-I are increased during human pregnancy.
Hormone research 2004;62(5):215-20.
2003: Höybye Charlotte; Frystyk Jan; Thorén Marja
The growth hormone-insulin-like growth factor axis in adult patients with Prader Willi syndrome.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2003;13(5):269-74.
2003: Nørrelund Helene; Nair K Sreekumaran; Nielsen Steen; Frystyk Jan; Ivarsen Per; Jørgensen Jens Otto Lunde; Christiansen Jens Sandahl; Møller Niels
The decisive role of free fatty acids for protein conservation during fasting in humans with and without growth hormone.
The Journal of clinical endocrinology and metabolism 2003;88(9):4371-8.
2003: Nørrelund Helene; Frystyk Jan; Jørgensen Jens Otto Lunde; Møller Niels; Christiansen Jens Sandahl; Ørskov Hans; Flyvbjerg Allan
The effect of growth hormone on the insulin-like growth factor system during fasting.
The Journal of clinical endocrinology and metabolism 2003;88(7):3292-8.
2003: Andersen Marianne; Hagen Casper; Frystyk Jan; Schroeder Henrik Daa; Hagen Claus
Development of acromegaly in patients with prolactinomas.
European journal of endocrinology / European Federation of Endocrine Societies 2003;149(1):17-22.
2003: Frystyk Jan; Nyholm Birgit; Skjaerbaek Christian; Baxter Robert C; Schmitz Ole; Ørskov Hans
The circulating IGF system and its relationship with 24-h glucose regulation and insulin sensitivity in healthy subjects.
Clinical endocrinology 2003;58(6):777-84.
2003: Chen Jian-Wen; Ledet Thomas; Orskov Hans; Jessen Niels; Lund Sten; Whittaker Jonathan; De Meyts Pierre; Larsen Maj Britt; Christiansen Jens Sandahl; Frystyk Jan
A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum.
American journal of physiology. Endocrinology and metabolism 2003;284(6):E1149-55.
2003: Boger Rainer H; Frystyk Jan; Ledet Thomas; Moller Niels; Flyvbjerg Allan; Orskov Hans
Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease.
Circulation 2003;107(20):e193; author reply e193.
2003: Amin Rakesh; Schultz Carl; Ong Ken; Frystyk Jan; Dalton R Neil; Perry Les; Ørskov Hans; Dunger David B;
Low IGF-I and elevated testosterone during puberty in subjects with type 1 diabetes developing microalbuminuria in comparison to normoalbuminuric control subjects: the Oxford Regional Prospective Study.
Diabetes care 2003;26(5):1456-61.
2003: Frystyk J; Bek T; Flyvbjerg A; Skjaerbaek C; Ørskov H
The relationship between the circulating IGF system and the presence of retinopathy in Type 1 diabetic patients.
Diabetic medicine : a journal of the British Diabetic Association 2003;20(4):269-76.
2003: Møller Niels; Nygren Jonas; Hansen Troels Krarup; ØRskov Hans; Frystyk Jan; Nair K Sreekumaran
Splanchnic release of ghrelin in humans.
The Journal of clinical endocrinology and metabolism 2003;88(2):850-2.
2003: Krassas G E; Pontikides N; Kaltsas T; Dumas A; Frystyk J; Chen J W; Flyvbjerg A
Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease.
The Journal of clinical endocrinology and metabolism 2003;88(1):132-5.
2003: Espelund Ulrick; Hansen Troels Krarup; Ørskov Hans; Frystyk Jan
Assessment of ghrelin.
APMIS. Supplementum 2003;(109):140-5.
2002: Rosendal Lars; Langberg Henning; Flyvbjerg Allan; Frystyk Jan; Ørskov Hans; Kjaer Michael
Physical capacity influences the response of insulin-like growth factor and its binding proteins to training.
Journal of applied physiology (Bethesda, Md. : 1985) 2002;93(5):1669-75.
2002: Yakar Shoshana; Rosen Clifford J; Beamer Wesley G; Ackert-Bicknell Cheryl L; Wu Yiping; Liu Jun-Li; Ooi Guck T; Setser Jennifer; Frystyk Jan; Boisclair Yves R; LeRoith Derek
Circulating levels of IGF-1 directly regulate bone growth and density.
The Journal of clinical investigation 2002;110(6):771-81.
2002: Frystyk Jan; Ledet Thomas; Møller Niels; Flyvbjerg Allan; Orskov Hans
Cardiovascular disease and insulin-like growth factor I.
Circulation 2002;106(8):893-5.
2002: Støving R K; Andersen M; Flyvbjerg A; Frystyk J; Hangaard J; Vinten J; Koldkjaer O G; Hagen C
Indirect evidence for decreased hypothalamic somatostatinergic tone in anorexia nervosa.
Clinical endocrinology 2002;56(3):391-6.
2002: Frystyk Jan; Højlund Kurt; Rasmussen Kirsten Nyborg; Jørgensen Søren Peter; Wildner-Christensen Mette; Ørskov Hans
Development and clinical evaluation of a novel immunoassay for the binary complex of IGF-I and IGF-binding protein-1 in human serum.
The Journal of clinical endocrinology and metabolism 2002;87(1):260-6.
2001: Yakar S; Liu J L; Fernandez A M; Wu Y; Schally A V; Frystyk J; Chernausek S D; Mejia W; Le Roith D
Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity.
Diabetes 2001;50(5):1110-8.
2001: Frystyk J; Ivarsen P; Støving R K; Dall R; Bek T; Hagen C; Ørskov H
Determination of free insulin-like growth factor-I in human serum: comparison of ultrafiltration and direct immunoradiometric assay.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2001;11(2):117-27.
2001: Gravholt C H; Frystyk J; Flyvbjerg A; Orskov H; Christiansen J S
Reduced free IGF-I and increased IGFBP-3 proteolysis in Turner syndrome: modulation by female sex steroids.
American journal of physiology. Endocrinology and metabolism 2001;280(2):E308-14.
2000: Frystyk J
Role of IGFBP-1 in glucose regulation?
Acta paediatrica (Oslo, Norway : 1992) 2000;89(9):1025-7.
2000: Skjaerbaek C; Frystyk J; Kaal A; Laursen T; Møller J; Weeke J; Jørgensen J O; Sandahl Christiansen J; Orskov H
Circadian variation in serum free and total insulin-like growth factor (IGF)-I and IGF-II in untreated and treated acromegaly and growth hormone deficiency.
Clinical endocrinology 2000;52(1):25-33.
1999: Frystyk J; Ivarsen P; Skjaerbaek C; Flyvbjerg A; Pedersen E B; Orskov H
Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.
Kidney international 1999;56(6):2076-84.
1999: Frystyk J; Skjaerbaek C; Vestbo E; Fisker S; Orskov H
Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
Diabetes/metabolism research and reviews 1999;15(5):314-22.
1999: Ivarsen P; Frystyk J; Pedersen E B
The pattern of intracellular free amino acids in granulocytes from hemodialysis patients change to an oral protein supplement (granulocyte amino acids after protein in HD patients).
Clinical nephrology 1999;52(2):110-8.
1999: Jensen P B; Hansen T B; Frystyk J; Ladefoged S D; Pedersen F B; Christiansen J S
Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
Clinical nephrology 1999;52(2):103-9.
1999: Frystyk J; Hussain M; Skjaerbaek C; Pørksen N; Froesch E R; Orskov H
The pharmacokinetics of free insulin-like growth factor-I in healthy subjects.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 1999;9(2):150-6.
1999: Støving R K; Flyvbjerg A; Frystyk J; Fisker S; Hangaard J; Hansen-Nord M; Hagen C
Low serum levels of free and total insulin-like growth factor I (IGF-I) in patients with anorexia nervosa are not associated with increased IGF-binding protein-3 proteolysis.
The Journal of clinical endocrinology and metabolism 1999;84(4):1346-50.
1999: Skjaerbaek C; Frystyk J; Grøfte T; Flyvbjerg A; Lewitt M S; Baxter R C; Orskov H
Serum free insulin-like growth factor-I is dose-dependently decreased by methylprednisolone and related to body weight changes in rats.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 1999;9(1):74-80.
1998: Frystyk J; Grønbaek H; Skjaerbaek C; Flyvbjerg A; Orskov H; Baxter R C
Developmental changes in serum levels of free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit in rats.
Endocrinology 1998;139(10):4286-92.
1998: Skjaerbaek C; Frystyk J; Orskov H; Kissmeyer-Nielsen P; Jensen M B; Laurberg S; Møller N; Flyvbjerg A
Differential changes in free and total insulin-like growth factor I after major, elective abdominal surgery: the possible role of insulin-like growth factor-binding protein-3 proteolysis.
The Journal of clinical endocrinology and metabolism 1998;83(7):2445-9.
1998: Frystyk J; Skjaerbaek C; Zapf J; Orskov H
Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia.
Diabetologia 1998;41(5):589-94.
1997: Frystyk J; Hussain M; Skjaerbaek C; Schmitz O; Christiansen J S; Froesch E R; Orskov H
Serum free IGF-I during a hyperinsulinemic clamp following 3 days of administration of IGF-I vs. saline.
The American journal of physiology 1997;273(3 Pt 1):E507-13.
1997: Frystyk J; Grøfte T; Skjaerbaek C; Orskov H
The effect of oral glucose on serum free insulin-like growth factor-I and -II in health adults.
The Journal of clinical endocrinology and metabolism 1997;82(9):3124-7.
1997: Skjaerbaek C; Vahl N; Frystyk J; Hansen T B; Jørgensen J O; Hagen C; Christiansen J S; Orskov H
Serum free insulin-like growth factor-I in growth hormone-deficient adults before and after growth hormone replacement.
European journal of endocrinology / European Federation of Endocrine Societies 1997;137(2):132-7.
1996: Skjaerbaek C; Frystyk J; Møller J; Christiansen J S; Orskov H
Free and total insulin-like growth factors and insulin-like growth factor binding proteins during 14 days of growth hormone administration in healthy adults.
European journal of endocrinology / European Federation of Endocrine Societies 1996;135(6):672-7.
1996: Vinter-Jensen L; Juhl C O; Frystyk J; Dajani E Z; Oksbjerg N; Flyvbjerg A
The effect of epidermal growth factor on circulating levels of IGF and IGF-binding proteins in adult Goettingen minipigs.
The Journal of endocrinology 1996;151(3):401-7.
1996: Møller N; Frystyk J; Skjaerbaek C; Pedersen H B; Christensen C; Schmitz O; Gee A; Gjedde A; Zapf J; Orskov H
Systemic and regional tumour metabolism in a patient with non-islet cell tumour hypoglycaemia: role of increased levels of free insulin-like growth factors.
Diabetologia 1996;39(12):1534-5.
1996: Scharf J G; Schmitz F; Frystyk J; Skjaerbaek C; Moesus H; Blum W F; Ramadori G; Hartmann H
Insulin-like growth factor-I serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease.
Journal of hepatology 1996;25(5):689-99.
1996: Frystyk J; Skjaerbaek C; Alexander N; Emanuelsson H; Suryapranata H; Beyer H; Foegh M; Orskov H
Lanreotide reduces serum free and total insulin-like growth factor-I after angioplasty.
Circulation 1996;94(10):2465-71.
1996: Grønbaek H; Nielsen B; Frystyk J; Flyvbjerg A; Orskov H
Effect of lanreotide on local kidney IGF-I and renal growth in experimental diabetes in the rat.
Experimental nephrology 1996;4(5):295-303.
1996: Fisker S; Frystyk J; Skriver L; Vestbo E; Ho K K; Orskov H
A simple, rapid immunometric assay for determination of functional and growth hormone-occupied growth hormone-binding protein in human serum.
European journal of clinical investigation 1996;26(9):779-85.
1996: Marshall S M; Hansen K W; Osterby R; Frystyk J; Orskov H; Flyvbjerg A
Effects of heparin on renal morphology and albuminuria in experimental diabetes.
The American journal of physiology 1996;271(2 Pt 1):E326-32.
1996: Frystyk J; Vinter-Jensen L; Skjaerbaek C; Flyvbjerg A
The effect of epidermal growth factor on circulating levels of free and total IGF-I and IGF-binding proteins in adult rats.
Growth regulation 1996;6(1):48-54.
1995: Frystyk J; Dinesen B; Orskov H
Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II.
Growth regulation 1995;5(4):169-76.
1995: Frystyk J; Grønbaek H; Skjaerbaek C; Flyvbjerg A
Effect of hyperthyroidism on circulating levels of free and total IGF-I and IGFBPs in rats.
The American journal of physiology 1995;269(5 Pt 1):E840-5.
1995: Grønbaek H; Nielsen B; Frystyk J; Orskov H; Flyvbjerg A
Effect of octreotide on experimental diabetic renal and glomerular growth: importance of early intervention.
The Journal of endocrinology 1995;147(1):95-102.
1995: Frystyk J; Vestbo E; Skjaerbaek C; Mogensen C E; Orskov H
Free insulin-like growth factors in human obesity.
Metabolism: clinical and experimental 1995;44(10 Suppl 4):37-44.
1995: Grønbaek H; Skjaerbaek C; Nielsen B; Frystyk J; Foegh M L; Flyvbjerg A; Orskov H
Growth hormone and insulin-like growth factor-I: a suggested role in renal transplantation and graft vessel disease.
Transplantation proceedings 1995;27(3):2133-6.
1995: Grønbaek H; Frystyk J; Orskov H; Flyvbjerg A
Effect of sodium selenite on growth, insulin-like growth factor-binding proteins and insulin-like growth factor-I in rats.
The Journal of endocrinology 1995;145(1):105-12.
1994: Frystyk J; Skjaerbaek C; Dinesen B; Orskov H
Free insulin-like growth factors (IGF-I and IGF-II) in human serum.
FEBS letters 1994;348(2):185-91.
1994: Howell M; Orskov H; Frystyk J; Flyvbjerg A; Grønbaek H; Foegh M
Lanreotide, a somatostatin analogue, reduces insulin-like growth factor I accumulation in proliferating aortic tissue in rabbits in vivo. A preliminary study.
European journal of endocrinology / European Federation of Endocrine Societies 1994;130(4):422-5.
1994: Wolthers T; Grøfte T; Flyvbjerg A; Frystyk J; Vilstrup H; Orskov H; Foegh M
Dose-dependent stimulation of insulin-like growth factor-binding protein-1 by lanreotide, a somatostatin analog.
The Journal of clinical endocrinology and metabolism 1994;78(1):141-4.
1993: Orskov H; Flyvbjerg A; Frystyk J; Grønbaek H; Foegh M; Harris A G
IGF-1 and acute renal hypertrophy: inhibition by somatostatin analogues.
Transplantation proceedings 1993;25(2):2061-2.
1992: Orskov H; Flyvbjerg A; Frystyk J; Ledet T; Møller N; Christensen S E; Harris A G
Octreotide and diabetes: theoretical and experimental aspects.
Metabolism: clinical and experimental 1992;41(9 Suppl 2):66-71.
1992: Flyvbjerg A; Frystyk J; Osterby R; Orskov H
Kidney IGF-I and renal hypertrophy in GH-deficient diabetic dwarf rats.
The American journal of physiology 1992;262(6 Pt 1):E956-62.
1992: Flyvbjerg A; Marshall S M; Frystyk J; Rasch R; Bornfeldt K E; Arnqvist H; Jensen P K; Pallesen G; Orskov H
Insulin-like growth factor I in initial renal hypertrophy in potassium-depleted rats.
The American journal of physiology 1992;262(6 Pt 2):F1023-31.
1992: Flyvbjerg A; Marshall S M; Frystyk J; Hansen K W; Harris A G; Orskov H
Octreotide administration in diabetic rats: effects on renal hypertrophy and urinary albumin excretion.
Kidney international 1992;41(4):805-12.
1991: Marshall S M; Flyvbjerg A; Frystyk J; Korsgaard L; Orskov H
Renal insulin-like growth factor I and growth hormone receptor binding in experimental diabetes and after unilateral nephrectomy in the rat.
Diabetologia 1991;34(9):632-9.
1990: Flyvbjerg A; Frystyk J; Marshall S M
Additive increase in kidney insulin-like growth factor I and initial renal enlargement in uninephrectomized-diabetic rats.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1990;22(10):516-20.
1989: Flyvbjerg A; Frystyk J; Thorlacius-Ussing O; Orskov H
Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats.
Diabetologia 1989;32(4):261-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Jan Frystyk

Research Profile (preview)

Chemicals & Drugs

Disorders

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Jan Frystyk (preview)

All Publications